文献速递肝胆胰外科

胰体尾腺癌切缘1毫米界值验证研究

Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
PubMed 文献 · Br J Surg · 2018-05-08

基于前瞻性数据库纳入2006至2014年行远端或全胰切除的胰体尾腺癌455例,按1毫米切缘界值评估R状态。

要点

  • 1毫米切缘界值下R状态是胰体尾腺癌切除后独立生存决定因素。

核心结论

  • 至少1毫米的切缘界值评估R状态是胰体尾腺癌切除后生存的独立决定因素。

研究设计与样本

  • 切缘按预设1毫米界值评估,采用Kaplan-Meier法分析总生存,并行单因素与多因素Cox回归。

关键数值与推荐

  • 切缘评估采用至少1毫米无肿瘤浸润作为R0界值。
  • R1(<1毫米)指切缘1毫米内见浸润,R1(直接)指肿瘤直接侵犯切缘。

临床怎么用

  • 胰体尾腺癌切除标本应采用1毫米切缘界值报告R状态以判断预后。
  • R1(<1毫米)与R1(直接)患者生存较差,可考虑更积极辅助治疗或密切随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The definition of resection margin (R) status in pancreatic cancer is under debate. Although a margin of at least 1 mm is an independent predictor of survival after resection for pancreatic head cancer, its relevance to pancreatic body and tail cancers remains unclear. This study aimed to validate R status based on a 1-mm tumour-free margin as a prognostic factor for resected adenocarcinoma involving the pancreatic body and tail. METHODS: Patients who underwent distal or total pancreatectomy for adenocarcinomas of the pancreatic body and tail between January 2006 and December 2014 were identified from a prospective database. Resection margins were evaluated using a predefined cut-off of 1 mm. Rates of R0, R1 with invasion within 1 mm of the margin (R1 less than 1 mm), and R1 with direct invasion of the resection margin (R1 direct) were determined, and overall survival in each group assessed by Kaplan-Meier analysis. Univariable and multivariable Cox regression analyses were performed to identify predictors of survival. RESULTS: R0 resection was achieved in 107 (23·5 per cent) and R1 in 348 (76·5 per cent) of 455 patients. Among R1 resections, invasion within 1 mm of the margin was found in 104 (22·9 per cent) and direct invasion in 244 (53·6 per cent). The R0 rate was 28·9 per cent after distal and 18·6 per cent after total pancreatectomy. In the total cohort, median survival times for patients with R0, R1 (less than 1 mm) and R1 (direct) status were 62·4, 24·6 and 17·2 months respectively, with 5-year survival rates of 52·6, 16·8 and 13·0 per cent (P < 0·001). In patients who received adjuvant chemotherapy, respective median survival times were 68·6, 32·8 and 21·4 months, with 5-year survival rates of 56, 22 and 16·0 per cent (P < 0·001). In multivariable analysis, R status was independently associated with survival. CONCLUSION: A cut-off of at least 1 mm for evaluation of resection margins is an independent determinant of survival after resection of adenocarcinomas of the pancreatic body and tail.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Hank T, Hinz U, Tarantino I, et al. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. Br J Surg. 2018. PMID: 29738626. doi:10.1002/bjs.10842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。